Home
>
National Drug Code (NDC)
>
Primidone
Primidone - 0591-5321-01 - (Primidone)
Drug Information of Primidone
| Product NDC: | 0591-5321 |
| Proprietary Name: | Primidone |
| Non Proprietary Name: | Primidone |
| Active Ingredient(s): | 250 mg/1 & nbsp; Primidone |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Primidone
| Product NDC: | 0591-5321 |
| Labeler Name: | Watson Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA083551 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100619 |
Package Information of Primidone
| Package NDC: | 0591-5321-01 |
| Package Description: | 100 TABLET in 1 BOTTLE, PLASTIC (0591-5321-01) |
NDC Information of Primidone
| NDC Code | 0591-5321-01 |
| Proprietary Name | Primidone |
| Package Description | 100 TABLET in 1 BOTTLE, PLASTIC (0591-5321-01) |
| Product NDC | 0591-5321 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Primidone |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20100619 |
| Marketing Category Name | ANDA |
| Labeler Name | Watson Laboratories, Inc. |
| Substance Name | PRIMIDONE |
| Strength Number | 250 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |
